3.40
+0.215(+6.75%)
Currency In USD
Address
350 Hills Street
Seattle, WA 99354
United States of America
Phone
509 375 1202
Sector
Healthcare
Industry
Medical - Devices
Employees
138
First IPO Date
November 10, 2005
| Name | Title | Pay | Year Born |
| Mr. Johan M. Spoor | Chief Executive Officer & Director | 948,223 | 1972 |
| Mr. Jonathan R. Hunt | Chief Accounting Officer | 611,165 | 1967 |
| Dr. Markus Puhlmann M.B.A., M.D. | Chief Medical Officer | 702,243 | 1966 |
| Mr. Andrew Bright | Executive Vice President of Brachytherapy | 0 | N/A |
| Mr. Amos Hedt BA, PGradDip | Chief Business Strategy Officer | 0 | N/A |
| Ms. Annie J. Cheng | Vice President of Investor Relations | 0 | 1976 |
| Mr. Shane Cobb | Executive Vice President of Operations | 0 | N/A |
| Dr. Michael K. Schultz Ph.D. | Chief Science Officer | 0 | N/A |
| Mr. Chris Nenno | General Counsel & Corporate Secretary | 0 | N/A |
| Mr. Juan Graham | Chief Financial Officer | 0 | 1977 |
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.